Avidity Partners Management LP
Follow13F filer, CIK 1791827, DALLAS, TX
Avidity Partners Management LP reported $488,204,016 across 18 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 98.09% of the portfolio.
Accepted , ingested 13F-HR 0001791827-26-000008
- Period
- 2026-09-30
- Reported value
- $488M
- Holdings
- 18
- Top 10 weight
- 98.09%
- New
- 1
- Sold out
- 28
Part of the filer group Avidity Partners Management LP
Avidity Capital Partners Fund (GP) LPAvidity Capital Partners (GP) LLC
- Avidity Capital Partners Fund (GP) LP
- Avidity Capital Partners (GP) LLC
- Avidity Partners Management (GP) LLC
- Avidity Private Master Fund I LP
- Michael Gregory
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| JBIOadded | +299,292 | $4.21M |
| ORKAadded | +25,000 | $2.08M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| DNTHreduced | -204,591 | -$18M |
| SENSreduced | -1,500,000 | -$15.3M |
| RGENexited | -77,800 | -$10.6M |
| PVLAreduced | -50,000 | -$6.9M |
| TEVAexited | -200,000 | -$6.78M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2026
Share positions as resolved from 13F-HR 0001791827-26-000008, largest first. % of portfolio is the value over $427,947,516, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| DNTHDIANTHUS THERAPEUTICS INC | 1,899,593 | $167M | 39.08% | -204,591 | Timeline | ||
| CGONCG ONCOLOGY INC | 1,348,948 | $95.6M | 22.35% | -50,000 | Timeline | ||
| ORKAORUKA THERAPEUTICS INC | 785,424 | $65.4M | 15.29% | +25,000 | Timeline | ||
| JBIOJADE BIOSCIENCES INC | 2,000,000 | $28.1M | 6.57% | +299,292 | Timeline | ||
| ELVNENLIVEN THERAPEUTICS INC | 550,000 | $25.2M | 5.89% | 0 | Timeline | ||
| CATXPERSPECTIVE THERAPEUTICS INC | 6,067,999 | $16.7M | 3.9% | -232,000 | Timeline | ||
| AKTSAKTIS ONCOLOGY INC | 484,200 | $9.43M | 2.2% | 0 | Timeline | ||
| IMUXIMMUNIC INC | 669,941 | $6.23M | 1.46% | 0 | Timeline | ||
| MOBIMOBIA MED INC | 324,676 | $3.07M | 0.72% | -473,606 | Timeline | ||
| PVLAPALVELLA THERAPEUTICS INC NE | 20,000 | $2.76M | 0.64% | -50,000 | Timeline | ||
| NVCTNUVECTIS PHARMA INC | 100,415 | $2.12M | 0.5% | -99,585 | Timeline | ||
| MSLESATELLOS BIOSCIENCE INC | 164,019 | $1.39M | 0.33% | -223,750 | Timeline | ||
| CNTXCONTEXT THERAPEUTICS INC | 4,060,254 | $1.22M | 0.29% | -938,013 | Timeline | ||
| KPTIKARYOPHARM THERAPEUTICS INC | 884,900 | $1.08M | 0.25% | -39,587 | Timeline | ||
| SENSSENSEONICS HLDGS INC | 100,000 | $1.02M | 0.24% | -1,500,000 | Timeline | ||
| SCYXSCYNEXIS INC | 153,613 | $759K | 0.18% | -106,593 | Timeline | ||
| AVLNAVALYN PHARMACEUTICALS INC | 20,000 | $570K | 0.13% | -40,000 | Timeline |
Options
Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).
| Security | Type | Amount | Value | Change |
|---|---|---|---|---|
| CGONCG ONCOLOGY INC COMMON STOCK | call | 850,000 | $60.3M | new |
Sold out in Q3 2026
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| RGENREPLIGEN CORP | 77,800 | $10.6M | shares |
| TEVATEVA PHARMACEUTICAL INDS LTD | 200,000 | $6.78M | shares |
| DXCMDEXCOM INC | 100,000 | $6.74M | shares |
| TEMTEMPUS AI INC | 105,000 | $6.08M | shares |
| MDTMEDTRONIC PLC | 70,000 | $5.48M | shares |
| VIRVIR BIOTECHNOLOGY INC | 519,300 | $5.29M | shares |
| GPCRSTRUCTURE THERAPEUTICS INC | 98,000 | $5.26M | shares |
| EHCENCOMPASS HEALTH CORP | 42,000 | $4.25M | shares |
| TENXTENAX THERAPEUTICS INC | 265,934 | $3.87M | shares |
| PODDINSULET CORP | 24,000 | $3.65M | shares |
| BSXBOSTON SCIENTIFIC CORP | 80,000 | $3.41M | shares |
| ALMRALAMAR BIOSCIENCES INC | 110,000 | $2.98M | shares |
| GILDGILEAD SCIENCES INC | 20,000 | $2.53M | shares |
| CRLCHARLES RIV LABS INTL INC | 10,000 | $2.27M | shares |
| PHATPHATHOM PHARMACEUTICALS INC | 200,000 | $2.17M | shares |
| KLRAKAILERA THERAPEUTICS INC | 80,000 | $1.76M | shares |
| GMABGENMAB A/S | 50,000 | $1.37M | shares |
| NTLAINTELLIA THERAPEUTICS INC | 75,000 | $1.27M | shares |
| CRVSCORVUS PHARMACEUTICALS INC | 80,000 | $1.2M | shares |
| ODDODDITY TECH LTD | 70,000 | $1.06M | shares |
| EVMNEVOMMUNE INC | 75,000 | $997K | shares |
| ABTABBOTT LABORATORIES | 10,000 | $907K | shares |
| BBIOBRIDGEBIO PHARMA INC | 10,000 | $745K | shares |
| PTONPELOTON INTERACTIVE INC | 100,000 | $591K | shares |
| LEGNLEGEND BIOTECH CORP | 15,000 | $433K | shares |
| BBOTBRIDGEBIO ONCOLOGY THERAPEUT | 43,853 | $334K | shares |
| SVRASAVARA INC | 50,000 | $308K | shares |
| TRVITREVI THERAPEUTICS INC | 6,660 | $124K | shares |
How Q3 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001791827-26-000008 | base | 2026-11-16 |